Clinical Value of Detecting Tumor Endothelial Marker 8 (ANTXR1) as a Biomarker in the Diagnosis and Prognosis of Colorectal Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Xu G, Zhou Y, Zhou F. Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I–III patients with colorectal cancer after operation. Cancer Manag Res. 2018;10:4051–4064. doi:10.2147/CMAR.S17445230323661
   PubMed Web of Science ®Google Scholar
• Zhong W, Yu Z, Zhan J, et al. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer. Pathol Oncol Res. 2015;21:83–95. doi:10.1007/s12253-014-9791-924875250
   PubMed Web of Science ®Google Scholar
• van der Geest LG, Lam-Boer J, Koopman M, Verhoef C, Elferink MA, de Wilt JH. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32:457–465. doi:10.1007/s10585-015-9719-025899064
   PubMed Web of Science ®Google Scholar
• Lech G, Slotwinski R, Krasnodebski IW. The role of tumor markers and biomarkers in colorectal cancer. Neoplasma. 2014;61:1–8. doi:10.4149/neo_2014_00324195503
   PubMed Web of Science ®Google Scholar
• Wang P, Li C, Zhang F, Ma X, Gai X. Clinical value of combined determination of serum B7-H4 with carcinoembryonic antigen, osteopontin, or tissue polypeptide-specific antigen for the diagnosis of colorectal cancer. Dis Markers. 2018;2018:4310790. doi:10.1155/2018/431079030363700
   PubMed Web of Science ®Google Scholar
• Ma ZY, Law WL, Ng EKO, et al. Methylated septin 9 and carcinoembryonic antigen for serological diagnosis and monitoring of patients with colorectal cancer after surgery. Sci Rep. 2019;9:10326. doi:10.1038/s41598-019-46876-431316143
   PubMed Web of Science ®Google Scholar
• Naumov GN, Akslen LA, Folkman J. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle. 2006;5:1779–1787. doi:10.4161/cc.5.16.301816931911
   PubMed Web of Science ®Google Scholar
• Baluk P, Hashizume H, McDonald DM. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev. 2005;15:102–111. doi:10.1016/j.gde.2004.12.00515661540
   PubMed Web of Science ®Google Scholar
• Folkman J, Kerbel R. Role of angiogenesis in tumor growth and metastasis clinical translation of angiogenesis inhibitors. Semin Oncol. 2002;29:15–18. doi:10.1053/sonc.2002.37263
   PubMed Web of Science ®Google Scholar
• Yamashita K, Watanabe M. Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Sci. 2009;100:195–199. doi:10.1111/j.1349-7006.2008.01022.x19200256
   PubMed Web of Science ®Google Scholar
• Nagy JA, Chang SH, Dvorak AM, Dvorak HF. Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer. 2009;100:865–869. doi:10.1038/sj.bjc.660492919240721
   PubMed Web of Science ®Google Scholar
• Pietrzyk Ł. Biomarkers discovery for colorectal cancer: a review on tumor endothelial markers as perspective candidates. Dis Markers. 2016;2016:4912405. doi:10.1155/2016/491240527965519
   PubMed Web of Science ®Google Scholar
• Frankel AE, Carter C, Kuo SR, Woo JH, Mauldin J, Liu JS. TEM8 targeted cancer therapy. Anticancer Agents Med Chem. 2011;11:983–992. doi:10.2174/18715201179792764322023048
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guo J, Zhang XL, et al. Antibody fragment-armed mesoporous silica nanoparticles for the targeted delivery of bevacizumab in ovarian cancer cells. Int J Pharm. 2015;496:1026–1033. doi:10.1016/j.ijpharm.2015.10.08026541303
   PubMed Web of Science ®Google Scholar
• St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science. 2000;289:1197–1202. doi:10.1126/science.289.5482.119710947988
   PubMed Web of Science ®Google Scholar
• Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell. 2007;11:539–554. doi:10.1016/j.ccr.2007.04.01717560335
   PubMed Web of Science ®Google Scholar
• Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res. 2001;61:6649–6655.11559528
   PubMed Web of Science ®Google Scholar
• Sun M, Li H, Liu J, Ning L, Zhao D, Liu S. The relationship between TEM8 and early diagnosis and prognosis of lung cancer. Minerva Med. 2020. doi:10.23736/S0026-4806.20.06444-7
   Web of Science ®Google Scholar
• Wang CX, Xiong HF, Wang S, et al. Overexpression of TEM8 promotes ovarian cancer progression via Rac1/Cdc42/JNK and MEK/ERK/STAT3 signaling pathways. Am J Transl Res. 2020;12:3557–3576.32774719
   PubMed Web of Science ®Google Scholar
• Høye AM, Tolstrup SD, Horton ER, et al. Tumor endothelial marker 8 promotes cancer progression and metastasis. Oncotarget. 2018;9:30173–30188. doi:10.18632/oncotarget.2573430046396
   PubMedGoogle Scholar
• Rmali KA, Watkins G, Harrison G, Parr C, Puntis MCA, Jiang WG. Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression. Eur J Surg Oncol. 2004;30:948–953. doi:10.1016/j.ejso.2004.07.02315498639
   PubMed Web of Science ®Google Scholar
• Duan HF, Hu XW, Chen JL, et al. Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8. J Natl Cancer Inst. 2007;99:1551–1555. doi:10.1093/jnci/djm13217925540
   PubMedGoogle Scholar
• Szot C, Saha S, Zhang XM, et al. Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release. J Clin Invest. 2018;128:2927–2943. doi:10.1172/JCI12048129863500
   PubMed Web of Science ®Google Scholar
• Albasri AM, Elkablawy MA, Hussainy AS, Yousif HM, Alhujaily AS. Impact of cyclooxygenase-2 over-expression on the prognosis of colorectal cancer patients. An experience from Western Saudi Arabia. Saudi Med J. 2018;39:773–780. doi:10.15537/smj.2018.8.2283730106414
   PubMed Web of Science ®Google Scholar
• Sun F, Peng HX, Gao QF, et al. Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients. Cancer Manag Res. 2018;10:2151–2161. doi:10.2147/CMAR.S16739830050325
   PubMed Web of Science ®Google Scholar
• Stiksma J, Grootendorst DC, van der Linden PW. CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. Clin Colorectal Cancer. 2014;13:239–244. doi:10.1016/j.clcc.2014.09.00425442815
   PubMed Web of Science ®Google Scholar
• Ogunwobi OO, Mahmood F, Akingboye A. Biomarkers in colorectal cancer: current research and future prospects. Int J Mol Sci. 2020;21:5311. doi:10.3390/ijms21155311
   PubMed Web of Science ®Google Scholar
• Pietrzyk Ł, Wdowiak P. Endosialin (TEM1) as a diagnostic, progression, and prognostic serum marker for patients with colorectal cancer-a preliminary study. Cancer Control. 2020;27:1073274820903351. doi:10.1177/107327482090335132107922
   PubMed Web of Science ®Google Scholar
• Pietrzyk Ł, Wdowiak P. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients. Adv Med Sci. 2019;64:402–408. doi:10.1016/j.advms.2019.07.00131352222
   PubMed Web of Science ®Google Scholar
• Maurya SK, Tewari M, Kumar M, Thakur MK, Shukla HS. Expression pattern of tumor endothelial marker 8 protein in gallbladder carcinomas. Asian Pac J Cancer Prev. 2011;12:507–512.21545221
   PubMedGoogle Scholar
• Raeisossadati R, Farshchian M, Ganji A, et al. Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients. Int J Colorectal Dis. 2011;26:1265–1270. doi:10.1007/s00384-011-1230-821573768
   PubMed Web of Science ®Google Scholar
• Opoku-Darko M, Yuen C, Gratton K, Sampson E, Bathe OF. Tumor endothelial marker 8 overexpression in breast cancer cells enhances tumor growth and metastasis. Cancer Invest. 2011;29:676–682. doi:10.3109/07357907.2011.62647422085271
   PubMed Web of Science ®Google Scholar